SCHEMBL4690450

SCHEMBL4690450

O=C(O)CCCCC[N+]12CCN(CC1)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.46
LMNA P02545 3/20 0.46
NFKB1 P19838 1/20 0.46
PMP22 Q01453 1/20 0.46
GPR84 Q9NQS5 8/20 0.40
BBOX1 O75936 2/20 0.40
FFAR1 O14842 2/20 0.40
FFAR4 Q5NUL3 2/20 0.40
PPARG P37231 6/20 0.39
PPARD Q03181 6/20 0.39
PPARA Q07869 6/20 0.39
HDAC11 Q96DB2 5/20 0.39
ALDH1A1 P00352 3/20 0.39
TLR2 O60603 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 2/20 0.39
FABP4 P15090 2/20 0.39
ALOX15 P16050 2/20 0.39
PTPN1 P18031 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3197897 0.98 TSHR (0.44) TSHRLMNANFKB1PMP22GPR84
Bromide SCHEMBL3187118 0.98 TSHR (0.44) TSHRLMNANFKB1PMP22GPR84
Bromide SCHEMBL4897598 0.82 BBOX1 (0.35) LMNABBOX1SLC22A6
Sebacic Acid SCHEMBL8435443 0.79 TSHR (0.67) TSHRLMNANFKB1PMP22GPR84
Bromide SCHEMBL19514188 0.79
Bromide SCHEMBL16968721 0.76
SCHEMBL19026195 0.70 KDM4E (0.35) ALDH1A1
SCHEMBL25186232 0.68 TSHR (1.00) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL301600 0.68 TSHR (1.00) TSHRLMNANFKB1PMP22GPR84
SCHEMBL21065467 0.68 TSHR (1.00) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517890-B1 CATIONICALLY SUBSTITUTED DIPHENYL AZETIDINONES, METHOD FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF SANOFI AVENTIS DEUTSCHLAND (DE) 2008-07-16 EP disclosed
EP-1517890-A1 CATIONICALLY SUBSTITUTED DIPHENYL AZETIDINONES, METHOD FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF Aventis Pharma Deutschland GmbH (DE) 2005-03-30 EP disclosed
WO-2004000803-A1 CATIONICALLY SUBSTITUTED DIPHENYL AZETIDINONES, METHOD FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-31 WO disclosed